3. Grant JP, Cox CE, Kleinman LM, et al: Serum hepatic enzyme and bilirubin elevations during parenteral nutrition. Surg Gynecol Obstet145:573–580, 1977
4.
4. Sax HC, Talamini MA, Brackett K, et al: Hepatic steatosis in TPN: Failure of fatty infiltration to correlate with abnormal serum hepatic enzyme levels. Surgery100:697–704, 1986
5.
5. Clark PJ, Ball MJ, Kettlewell MGW: Liver function tests in patients receiving parenteral nutrition. JPEN15:54–59, 1991
6.
6. Buchman AL, Moukarzel AA, Jenden DJ, et al: Low plasma free choline is prevalent in patients receiving long term parenteral nutrition and is associated with hepatic aminotransferase abnormalities. Clin Nutr12:33–37, 1993
8. Craig RM, Neumann T, Jeejeebhoy KN, et al: Severe hepatocellular reaction resembling alcoholic cirrhosis after massive small bowel resection and prolonged TPN. Gastroenterology79:131–137, 1980
9.
9. MacDonald GA, Bridle KR, Ward PJ, et al: Lipid peroxidation in hepatic steatosis in humans is associated with hepatic fibrosis and occurs predominately in acinar zone 3. J Gastroenterol Hepatol16:599–606, 2001
10.
10. Buchman AL, Ament ME: Liver disease and TPN. In Hepatology, A Textbook of Liver Disease, 3rd ed., Zakim D, Boyer TD (eds). WB Saunders, Philadelphia, PA,1962, pp 1810–1821
11.
11. Rabeneck L, Freeman H, Owen D: Death due to TPN-related liver failure [abstract]. Gastroenterology86:1215, 1984
12.
12. Bowyer BA, Fleming CR, Ludwig J, et al: Does long-term home parenteral nutrition in adult patients cause chronic liver disease?JPEN9:11–17, 1985
13.
13. Stanko RT, Nathan G, Mendelow H, et al: Development of hepatic cholestasis and fibrosis in patients with massive loss of intestine supported by prolonged parenteral nutrition. Gastroenterology92:197–202, 1987
14.
14. Cavicchi M, Beau P, Crenn P, et al: Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med132:525–532, 2000
15.
15. Chan S, McCowen KC, Bistrian BC, et al: Incidence, prognosis, and etiology of end-stage liver disease in patients receiving home TPN. Surgery126:28–34, 1999
16.
16. Sondheimer JM, Asturias E, Cadnapaphornchai M: Infection and cholestasis in neonates with intestinal resection and long-term parenteral nutrition. J Pediatr Gastroenterol Nutr27:131–137, 1998
17.
17. Drongowski RA, Coran AG: An analysis of the factors contributing to the development of TPN-induced cholestasis. JPEN13:586–589, 1989
18.
18. Hata S, Nezu R, Kubota A, et al: Effect of amino acids in TPN on cholestasis in newborn rabbits. J Pediatr Surg29:892–895, 1994
19.
19. Cook GC, Hutt MSR: The liver after kwashiokor. Br Med J3:454–457, 1967
20.
20. Reif S, Tano M, Oliverio R, et al: TPN-induced steatosis: Reversal by parenteral lipid infusion. JPEN15:102–104, 1991
21.
21. Karpati G, Carpenter S, Engel AG, et al: The syndrome of systemic carnitine deficiency: clinical, morphologic, biochemical and pathologic features. Neurology25:16–24, 1975
22.
22. Dahlstrom KA, Ament ME, Moukarzel A, et al: Low blood and plasma carnitine levels in children receiving long-term parenteral nutrition. J Pediatr Gastroenterol Nutr11:375–379, 1990
23.
23. Moukarzel AA, Dahlstrom KA, Buchman AL, et al: Carnitine status of children receiving long-term TPN: A longitudinal prospective study. J Pediatr120:759–762, 1992
24.
24. Bowyer BA, Fleming CR, Listrup D, et al: Plasma carnitine levels in patients receiving home parenteral nutrition. Am J Clin Nutr43:85–91, 1986
25.
25. Bowyer BA, Miles JM, Haymond MW, et al: L-camitine therapy in home parenteral nutrition patients with abnormal liver tests and low plasma carnitine concentration. Gastroenterology94:434–438, 1988
26.
26. Buchman AL, Dubin M, Jenden D, et al: Lecithin supplementation causes a decrease in hepatic steatosis in patients receiving long term parenteral nutrition. Gastroenterology.102:1363–1370,1992
27.
27. Buchman AL, Dubin M, Moukarzel A, et al: Choline deficiency: A cause of hepatic steatosis associated with parenteral nutrition that can be reversed with an intravenous choline chloride supplementation. Hepatology22:1399–1403, 1995
28.
28. Buchman AL, Sohel M, Dubin M, et al: Choline deficiency causes reversible hepatic abnormalities in patients during parenteral nutrition: Proof of a human choline requirement; a placebo-controlled trial. JPEN25:260–268, 2001
29.
29. Calabro A, Orsini B, Renzi D, et al: Expression of epidermal growth factor, transforming growth factor-alpha and their receptor in the human esophagus. Histochem J29:745–758, 1997
30.
30. Steginck LD, Besten LD: Synthesis of cysteine from methionine in normal adult subjects: effect of route of alimentation. Science178:514–516, 1972
31.
31. Chawla RK, Berry CJ, Kutner MH, et al: Plasma concentrations of transsulfuration pathway products during nasoenteral and intravenous hyperalimentation of malnourished patients. Am J Clin Nutr42:577–584, 1985
32.
32. Sheard NF, Tayek JA, Bistrian BR, et al: Plasma choline concentration in humans fed parenterally. Am J Clin Nutr43:219–224, 1986
34. Burk RF, Early DS, Hill KE: Plasma selenium in patients with cirrhosis. Hepatology27:794–798, 1998
35.
35. Grant JP, Snyder PJ: Effect of glutamine on total fat content of the liver [abstract]. JPEN14:8S, 1990
36.
36. Li S, Nussbaum MS, McFadden DW, et al: Addition of L-glutamine to TPN and its effects on portal insulin and glucagon and development of hepatic steatosis in the rat. J Surg Res48:421–426, 1990
37.
37. Yeh SL, Chen WJ, Huang PC: Effect of L-glutamine on hepatic lipids at different energy levels in rats receiving TPN. JPEN18:40–44, 1994
38.
38. Hornsby-Lewis L, Shike M, Brown P, et al: L-glutamine supplementation in home TPN patients: Stability, safety, and effects on intestinal absorption. JPEN18:268–273, 1994
39.
39. Okamoto E, Rassin DK, Zucker CL, et al: Role of taurine in feeding the low-birth-weight infant. J Pediatr104:936–940, 1984
40.
40. Desai TK, Reddy J, Kinzie JL, et al: Taurine supplementation and cholestasis during bone marrow transplantation. Gastroenterology104:A616, 1993
41.
41. Cooke RJ, Whitington PF, Kelts D: Effects of taurine supplementation on hepatic function during short-term parenteral nutrition in the premature infant. J Pediatr Gastroenterol3:234–238, 1984
42.
42. Dorvil NP, Yousef IM, Tuchweber B, et al: Taurine prevents cholestasis induced by lithocholic acid sulfate in guinea pigs. Am J Clin Nutr37:221–232, 1983
43.
43. Balistreri WF, Bucuvalas JC, Farrell MK, et al: TPN-associated cholestasis: Factors responsible for the decreasing incidence. In Falk Symposium 63, Pediatric Cholestasis. Novel Approaches to Treatment, Lentze M, Reichen J (eds). Kluwer Academic Publishers, London,1992
46. Clayton PT, Bowron A, Mills KA, et al: Phytosterolemia in children with parenteral nutrition-associated cholestatic liver disease. Gastroenterology105:1806–1813, 1993
47.
47. Lowry SF, Brennan MF: Abnormal liver function during parenteral nutrition: Relation to infusion excess. J Surg Res26:300–307. 1979
48.
48. Blue PR, Burnes JU, Kelly DG: Long-term parenteral nutrition (TPN)-associated hepatobiliary dysfunction: Are there predisposing factors?Gastroenterology104:A642, 1993
49.
49. Meguid MM, Akalioslii MP, Jeffers S, et al: Amllioration of metabolic complications of conventional parenteral nutrition. Arch Surg119:1294–1298, 1984
50.
50. Pappo I, Bercovier H, Berry EM, et al: Polymyxin B reduces TPN-associated hepatic steatosis by its antibacterial activity and by blocking deleterious effects of lipopolysaccharide. JPEN16:529–532, 1992
51.
51. Freund HR, Muggia-Sullam M, LaFrance R, et al: A possible beneficial effect of metronidazole in reducing TPN-associated liver function derangements. J Surg Res38:356–363, 1985
52.
52. Riordan SM, McIver CJ, Williams R: Liver damage in human small intestinal bacterial overgrowth. Am J Gastroenterol93:234–237, 1998
53.
53. Brand HS, Maas MA, Bosnia A, et al: Experimental colitis in rats induces low-grade endotoxinemia without hepatobiliary abnormalities. Dig Dis Sci39:1210–1215, 1994
54.
54. Pappo I, Bercovier H, Berry E, et al: Antitumor necrosis factor antibodies reduce hepatic steatosis during TPN and bowel rest in rats. JPEN19:80–82, 1995
55.
55. Lewittes M, Tuchwebr B, Weber A, et al: Resistance of the sucking guinea pig to lithocholic acid-induced cholestasis. Hepatology4:486–491, 1984
56.
56. Masumoto K, Suita S, Taguchi T, et al: Manganese intoxication during intermittent parenteral nutrition: Report of twoJPEN25:95–99, 2001
57.
57. Larsen NA, Pakkenberg H, Damsgaard E, et al: Topographical distribution of arsenic, manganese, and selenium in the normal human brain. J Neurol Sci42:458–468, 1979
58.
58. Klein GL, Sedman AB, Heyman MB, et al: Hepatic abnormllities associated with aluminum loading in piglets. JPEN11:293–297,1987
59.
59. Klein GL, Heyman MB, Lee TC, et al: Aluminum associated hepatobiliary dysfunction in rats: Relationships to dosage and duration of exposure. Pediatr Res23; 275–278, 1988
60.
60. Klein GL: The aluminum content of parenteral solutions: Current status. Nutr Rev49:74–79, 1991
61.
61. Capron JP, Herve MA, Gineston JL, et al: Metronidazole in prevention of cholestasis associated with TPN. Lancet26:446–447, 1983
62.
62. Lambert Jr, Thomas SM: Metronidazole prevention of serum liver enzyme abnormllities during TPN. JPEN9:501–503, 1985
63.
63. Lindor KD, Burnes J: Ursodeoxycholic acid for the treatment of home parenteral nutrition-associated cholestasis. Gastroenterology101:250–253, 1991
64.
64. Beau P, Labat-Labourdette J, Ingrand P, et al: Is ursodeoxycholic acid an effective therapy for TPN-related liver disease. J Hepatol20:240–244, 1994
65.
65. Cocjin J, Vanderhal A, Sehgal S, et al: Ursodeoxycholic acid therapy for TPN-associated cholestasis. Gastroenterology104: A615, 1993
66.
66. Spagnuolo MI, Iorio R, Vegnente A, et al: Ursodeoxycholic acid for treatment of cholestasis m children on long-term TPN: A pilot study. Gastroenterology111:716–719, 1996
67.
67. Levine A, Maayan A, Shamir R, et al: Parenteral nutrition-associated cholestasis in preterm neonates: Evaluation of ursodeoxycholic acid treatment. J Pediatr Endocrin Metab12:549–553, 1999
68.
68. Sudan DL, Kaufman SS, Shaw BW, et al: Isolated intestinal transplantation for intestinal failure. Am J Gastroenterol95:1506–1515, 2000
